Viral Vitalism

Medicine

NEJM

NEJM news, research, studies, and rapid health briefings. Visit Viral Vitalism for plain-language context, evidence boundaries, and related signals.

0 published articles2 rapid briefsBuilding this topic
Coverage is being assembled with research and source context before this hub is promoted publicly.

News cycle

Rapid Briefs

View all ->
Cancer ImmunotherapyConfirmed

Some Early CAR-T Lymphoma Patients Are Still Relapse-Free 10 Years Later

Penn's decade-long follow-up gives CAR-T cure language a stronger footing for a subset of lymphoma patients, while showing why not everyone should be promised the same outcome.

Why now

A 10-year follow-up gives CAR-T storytelling the missing timeline: not just response, but durable remission in some of the earliest lymphoma patients treated.

Overclaim risk
medium-high
Primary source
Official
Published
Jun 27, 2026
Read brief ->
Transplant MedicineConfirmed

CAR-T Helped Two Highly Sensitized Kidney Patients Receive Transplants

Penn's dual CAR-T desensitization report now has a stronger named-patient center: Andrew Boyd, 47, received the third kidney transplant he thought might never come.

Why now

A cancer-born cell therapy may have opened a transplant path for patients who were almost impossible to match.

Overclaim risk
high
Primary source
Official
Published
Jun 25, 2026
Read brief ->

Related topics

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.